Skip to Main Content

Author Details

Sanda Alexandrescu
2008
75
24
PMIDPaper TitleJournal TitlePublished Year
37532182ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.Mod Pathol2023
36271929Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.Acta Neuropathol2023
35604410Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.Neuro Oncol2023
36254350Mimics of Pediatric Small Vessel Primary Angiitis of the Central Nervous System.Ann Neurol2023
38037182H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications.2023
37870091Systematic Characterization of Antibody-Drug Conjugate Targets in Central Nervous System Tumors.2023
36780194ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma.Clin Cancer Res2023
37339758Eastern Equine Encephalitis Virus Diversity in Massachusetts Patients, 1938-2020.Am J Trop Med Hyg2023
36897259Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.Blood Adv2023
37141170Double-stranded RNA immunohistochemistry as a screening tool for viral encephalitis.2023
37126322Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy.JAMA Neurol2023
37057373Clear cell tumor with melanocytic differentiation and MITF::CREM translocation.2023
36933012Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.Acta Neuropathol2023
34821426Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas.Brain Pathol2022
35397478Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.Neuro Oncol2022
35384518DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.Journal of Neuro-Oncology2022
36057740PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.Modern Pathology2022
35716669Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas.Molecular Cell2022
36910592Copy Number Variation and Structural Genomic Findings in 116 Cases of Sudden Unexplained Death between 1 and 28 Months of Age.Adv Genet (Hoboken)2022
36471067The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location.Nat Genet2022
34857434Immunohistochemical surrogates for molecular alterations for the classification and grading of gliomas.Seminars in Diagnostic Pathology2022
34670408Endothelial <i>GNAQ</i> p.R183Q Increases ANGPT2 (Angiopoietin-2) and Drives Formation of Enlarged Blood Vessels.Arterioscler Thromb Vasc Biol2022
35266242Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - Advances in diagnosis and prognostication.Brain Pathology2022
34727172ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.Blood2022
35027292Genetic Determinants of Sudden Unexpected Death in Pediatrics.Genet Med2022
34580728Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.Journal of Neuropathology and Experimental Neurology2021
33571520Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasion.Brain Res2021
33565268Outcomes after first relapse of childhood intracranial ependymoma.Pediatric Blood and Cancer2021
33772213IDH-mutant gliomas with additional class-defining molecular events.Mod Pathol2021
34325058Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA Sequencing.Journal of Molecular Diagnostics2021
33141488Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms.Brain Pathol2021
32692439Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant.Histopathology2021
33051600Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.Mod Pathol2021
31375768Characterization of molecular signatures of supratentorial ependymomas.Mod Pathol2020
32322066Mechanisms and therapeutic implications of hypermutation in gliomas.Nature2020
32389264Embryonal Tumors of the Central Nervous System: An Update.Surgical Pathology Clinics2020
32389263An Update on Pediatric Gliomas.Surgical Pathology Clinics2020
32652122A de novo BRPF1 variant in a case of Sudden Unexplained Death in Childhood.Eur J Med Genet2020
32627129Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience.Journal of Neuro-Oncology2020
32667141Making the most of small samples: Optimization of tissue allocation of pediatric solid tumors for clinical and research use.Pediatric Blood and Cancer2020
32665022Molecular and clinicopathologic features of gliomas harboring NTRK fusions.Acta Neuropathol Commun2020
32663469Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma.Cancer Cell2020
30953130An update on the central nervous system manifestations of DICER1 syndrome.Acta Neuropathol2020
31044148Pediatric CNS-isolated hemophagocytic lymphohistiocytosis.Neurol Neuroimmunol Neuroinflamm2019
31802000The molecular landscape of ETMR at diagnosis and relapse.Nature2019
31631026Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG.Cancer Cell2019
31891627Somatic mutations in intracranial arteriovenous malformations.PLoS One2019
31571114Increasing value of autopsies in patients with brain tumors in the molecular era.J Neurooncol2019
30422215Association of Somatic GNAQ Mutation With Capillary Malformations in a Case of Choroidal Hemangioma.JAMA Ophthalmology2019
31140557Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors.Neuro Oncol2019
  • 1 - 50 of 75

Recommended Authors

Collaborators

Co-authored papers 17
Co-authored papers 10
Co-authored papers 8
Co-authored papers 7
University of California san francisco
Co-authored papers 6
St. Jude Children's Research Hospital
Co-authored papers 6
Dana-Farber Cancer Institute
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
University of California san francisco
Co-authored papers 5
Boston Children's Hospital
Co-authored papers 5
Boston Children's Hospital and Harvard Medical School
Co-authored papers 5
Co-authored papers 4
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 4
Co-authored papers 4
Boston Children's Hospital, Harvard Medical School
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Co-authored papers 4
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 3
Co-authored papers 3
University of California Los Angeles
Co-authored papers 3
Harvard Medical School
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
Co-authored papers 3
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 3
Harvard Medical School.
Co-authored papers 3